Literature DB >> 22199322

Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour.

Klaus-Peter Dieckmann1, Werner Jan Struss, Ulrich Budde.   

Abstract

BACKGROUND: Acute early vascular toxicity of chemotherapy for germ cell tumour (GCT) is poorly understood. To explore the pathogenesis of this complication we evaluated laboratory parameters associated with vascular disease. PATIENTS AND METHODS: In 33 GCT patients the following parameters were investigated with routine laboratory methods before and after chemotherapy: von Willebrand factor antigen (vWF:AG), collagen binding capacity (vWF:CB), lipoprotein (a), homocysteine, plasminogen activator inhibitor I, total cholesterol, high density lipoprotein, low density lipoprotein, troponine I. Statistical evaluation involved descriptive analysis and the Wilcoxon signed rank test.
RESULTS: Levels of vWF:AG and vWF:CB increased significantly upon therapy (p=0.002). All other parameters remained unchanged. Upon late measurement, vWF:AG and vWF:CB were normalised.
CONCLUSION: As von Willebrand factor is released from endothelial cells upon damage, we postulate that early vascular toxicity of chemotherapy is caused by direct damage of the vascular endothelium. Long-term vascular complications of chemotherapy appear to be different, pathogenetically.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199322

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

Review 1.  Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.

Authors:  Kelly C Gast; Paul V Viscuse; Somaira Nowsheen; Tufia C Haddad; Robert W Mutter; Andrea E Wahner Hendrickson; Fergus J Couch; Kathryn J Ruddy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-01

2.  VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity.

Authors:  Laurence M Black; Elisa R Farrell; Daria Barwinska; Gunars Osis; Anna A Zmijewska; Amie M Traylor; Stephanie K Esman; Subhashini Bolisetty; Grace Whipple; Malgorzata M Kamocka; Seth Winfree; Daryll R Spangler; Shehnaz Khan; Abolfazl Zarjou; Tarek M El-Achkar; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-18

Review 3.  Common Vascular Toxicities of Cancer Therapies.

Authors:  Joerg Herrmann
Journal:  Cardiol Clin       Date:  2019-08-26       Impact factor: 2.213

4.  Evaluation of cloned cells, animal model, and ATRA sensitivity of human testicular yolk sac tumor.

Authors:  Junfeng Zhao; Congde Chen; Haochuan Zhang; Jinhui Shen; Hua Zhang; Xiaokun Lin; Le Qin; Xiaozhou Bao; Jie Lin; Wenqiang Lu; Xiangdong Wang; Xiaoming Chen
Journal:  J Transl Med       Date:  2012-03-13       Impact factor: 5.531

5.  Far-infrared radiation alleviates cisplatin-induced vascular damage and impaired circulation via activation of HIF-1α.

Authors:  Cheng-Hsien Chen; Meng-Chuan Chen; Yung-Ho Hsu; Tz-Chong Chou
Journal:  Cancer Sci       Date:  2022-04-20       Impact factor: 6.518

6.  Factor V Leiden mutation triggering four major complications to standard dose cisplatin-chemotherapy for testicular seminoma: a case report.

Authors:  Klaus-Peter Dieckmann; Petra Anheuser; Ralf Gehrckens; Sven Philip Aries; Raphael Ikogho; Wiebke Hollburg
Journal:  BMC Urol       Date:  2015-03-17       Impact factor: 2.264

7.  Unusually Located Stroke After Chemotherapy in Testicular Germ Cell Tumors.

Authors:  Braulio Alexander Martinez; Edgar Patricio Correa
Journal:  J Investig Med High Impact Case Rep       Date:  2015-06-09

8.  Reply: Comment on 'Chemotherapy for testicular cancer induces acute alterations in diastolic heart function'.

Authors:  L D van Schinkel; P M Willemse; R W van der Meer; J Burggraaf; S G C van Elderen; J W A Smit; A de Roos; S Osanto; H J Lamb
Journal:  Br J Cancer       Date:  2013-11-07       Impact factor: 7.640

9.  Acute inferior myocardial infarction in a young man with testicular seminoma: A case report.

Authors:  Alexandru Scafa-Udriste; Nicoleta-Monica Popa-Fotea; Vlad Bataila; Lucian Calmac; Maria Dorobantu
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

Review 10.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.